Author

Beema T Yoosuf

Observed names: Beema T. Yoosuf, Yoosuf, Beema T

Institutions: INTI International University, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, Saveetha University

Observed institutions: INTI International University, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, Saveetha University

ORCID: 0009-0001-3584-6212

Observed ORCID: 0009-0001-3584-6212

OpenAlex ID: A5094042945

Comparative efficacy and safety of alpha-blockers as monotherapy for benign prostatic hyperplasia: a systematic review and network meta-analysis

2024 · Beema T Yoosuf, Abhilash Kumar Panda, et al. · Scientific Reports · 24

Risk of genitourinary tract infections with SGLT-2 inhibitors in type 2 diabetes mellitus: A meta-analysis of randomised controlled trials and disproportionality analysis using FAERS

2025 · Beema T Yoosuf, Muhammed Favas KT, et al. · Endocrine · 19

Epidemiology, transmission dynamics, treatment strategies, and future perspectives on Oropouche virus

2025 · Beema T Yoosuf, Abhay M Gaidhane, et al. · Diagnostic Microbiology and Infectious Disease · 12

Comprehensive safety profile of dipeptidyl peptidase-4 inhibitors: a post-marketing study based on FAERS database using signal detection algorithms

2024 · Beema T Yoosuf, Muhammed Favas KT, et al. · Expert Opinion on Drug Safety · 9

Comprehensive safety evaluation of isatuximab in multiple myeloma using disproportionality analysis of FAERS and meta-analysis of randomized controlled trials

2024 · Muhammed Favas Karimbanathottathil, Beema T Yoosuf, et al. · Scientific Reports · 8

Venetoclax adverse event monitoring: a safety meta-analysis of randomized controlled trials and a retrospective evaluation of the FAERS

2024 · Muhammed Favas KT, Maneesh Semwal, et al. · Annals of Hematology · 8

Concerns and implications of Oropouche virus infection during pregnancy: A call for further research and public health action

2024 · Beema T Yoosuf, Rachana Mehta, et al. · New Microbes and New Infections · 3

Role of Medical Coding in Signal Detection

2024 · Dipika Bansal, Beema T Yoosuf, et al. · CRC Press eBooks · 3

Mpox: transmission dynamics, treatment, and innovations

2025 · Prakasini Satapathy, Beema T. Yoosuf, et al. · Therapeutic Advances in Infectious Disease · 2

Bayesian Methods of Signal Detection

2024 · Dipika Bansal, Muhammed KT Favas, et al. · CRC Press eBooks · 2

Insights into the systemic risk factors associated with diabetic retinopathy in the Indian population: A comprehensive systematic review and meta-analysis

2024 · KT Muhammed Favas, Mamidi Niveditha, et al. · Indian Journal of Ophthalmology · 1

Author Correction: Comparative efficacy and safety of alpha-blockers as monotherapy for benign prostatic hyperplasia: a systematic review and network meta-analysis

2024 · Beema T Yoosuf, Abhilash Kumar Panda, et al. · Scientific Reports · 1

Cardiac Adverse Events Associated With Elotuzumab: A Disproportionality Analysis Using FDA Adverse Event Reporting System

2025 · Muhammed Favas K. T, Beema T. Yoosuf, et al. · Annals of Pharmacotherapy

Safety Profile of Istradefylline in Parkinson’s Disease: A Meta-Analysis of Randomized Controlled Trials and Disproportionality Analysis Using FAERS

2025 · Beema T Yoosuf, Suhani Jain, et al. · Journal of Geriatric Psychiatry and Neurology

Vorasidenib: A Milestone in Targeted Therapy for IDH-Mutant Lower Grade Gliomas - Efficacy, Emerging Safety Concerns, and the Call for Comprehensive Safety Evaluation

2024 · Beema T. Yoosuf, Manisa Pattanayak, et al. · Current Drug Safety

Works count: 17

Citation count: 92

H-index: 6

I10-index: 3